March 27, 2024
Media & Press relations
Our latest press releases
Swipe for more
-
March 14, 2024
bioMérieux – 2023 Financial Results
Today bioMérieux released its 2023 financial results. Consolidated sales amounted to €3,675 million in 2023, up 6.6% like-for-like from €3,589 million in the prior year period. -
January 08, 2024
bioMérieux acquires LUMED to reinforce its software portfolio in the fight against antimicrobial resistance
bioMérieux, a world leader in the field of in vitro diagnostics, announces the acquisition of LUMED, a software company that has developed a clinical decision support system to help hospitals optimize antimicrobial prescriptions and monitor healthcare-associated infections. -
December 06, 2023
Texas Children's Hospital Joins the bioMérieux Global Network of Antimicrobial Stewardship Centers of Excellence
Texas Children’s Hospital, a nonprofit health care organization, is the newest facility inducted into the bioMérieux global Antimicrobial Stewardship Center of Excellence program. bioMérieux, a world leader in in vitro diagnostics, is proud to partner with Texas Children’s.
Media contacts
Stephen Norton
Phone: (801) 940-9051
_____
Liza Deckelbaum
Phone: (919) 645-0782
_____
bioMérieux in the News
Helpful Resources